Besides the annual outbreaks of respiratory tract infections by influenza viruses, the selection pressure on circulating influenza viruses drives an antigenic drift of seasonal viruses leading to pandemics. Thus, there is a growing demand on seasonal influenza vaccines adapting to the current major virus strain. These optimal pandemic vaccines should fulfil certain requirements: 1) easy and safe administration; 2) strong and effective immune response; and 3) fast and economic way of high amount production in periods of pandemics. In this study we tested local immunotoxicity of a new nanoparticle-based inhalable influenza vaccine in murine and human precision cut lung slices (PCLS) ex vivo.
Murine and human PCLS were treated with different concentrations of SiO 2 -nanoparticles, plant-derived influenza H1N1 (A/California /04/09) antigen (HAC1) only or HAC1 antigen formulated with SiO 2 -nanoparticles (ratio HAC1:SiO 2 = 1 %). Tissue vitality was determined by WST-1 assay and live/dead staining. Cytokine secretion was measured by MSD and ELISA assays.
Introduction

Methods
The low toxicity and the induced T cell specific immunoregulatory cytokine profile confirmed that the formulation of an antigen with SiO 2nanoparticles is a promising system for pandemic influenza vaccine development.
Conclusion
Contact
However, the highest doses of SiO 2 are far above the intended human dosages, but were chosen to determine the limits of our test system.
The pro-inflammatory cytokine TNF-α was not induced by the different treatments. In contrast, human IL-8 and murine KC were significantly increased at high SiO 2 concentrations of 1000 µg/ml. Additionally, a dose-dependent increase of IL-2 and IFN-γ was observed in human PCLS for the antigen and the combined treatment of SiO 2nanoparticles and antigen.
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Results
Both, murine and human PCLS showed a trend towards attenuation of viability at high concentrations of SiO 2 with and without HAC1. 
Summary
We observed no cytotoxic effect of the viral protein HAC1 in living lung tissue.
The carrier nanoparticles SiO 2 was also non toxic at low concentrations in living lung. Higher concentrations showed adverse effects on viability, which was accompanied by the release of IL-8 & KC.
IL-2 & IFN-γ are immunologically induced by HAC1
